BML Investment Partners, L.P. 13D/13G Filings for LAVA Therapeutics N.V. (LVTX)

BML Investment Partners, L.P. 13D and 13G filings for LAVA Therapeutics N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-03
2:03 pm
Purchase
2025-02-2613GLAVA Therapeutics N.V.
LVTX
BML Investment Partners, L.P.1,958,110
7.400%
1,958,110increase
(New Position)
Filing